文献速递胸部头颈CT

双能CT参数鉴别甲状腺癌肺转移与良性肺结节

Differentiating pulmonary metastasis from benign lung nodules in thyroid cancer patients using dual-energy CT parameters.
PubMed 文献 · Eur Radiol · 2021-09-25

回顾性研究纳入63例病理证实的甲状腺癌患者,22例55个肺转移灶、41例97个良性结节,比较双能CT参数并行ROC分析。转移灶碘浓度、标准化碘浓度、能谱曲线斜率及有效原子序数均显著高于良性结节,NIC和IC诊断准确性最高,截止值分别为0.29和3.10。

要点

  • 甲状腺癌患者肺结节碘浓度>3.10 mg/mL或NIC>0.29时需警惕转移。
  • 双能CT参数在≥3 mm且<5 mm的小结节中仍可鉴别转移与良性。
  • NIC和IC诊断准确性最高,其次为NICPA和λHU。

关键影像表现/征象

  • 转移灶碘浓度(IC)为5.61±2.02 mg/mL,良性结节为1.61±0.98 mg/mL。
  • 转移灶标准化碘浓度(NIC)为0.60±0.20,良性结节为0.16±0.11。
  • 转移灶以肺动脉为参考的NIC(NICPA)为0.60±0.44,良性结节为0.15±0.11。
  • 转移灶能谱衰减曲线斜率(λHU)为5.18±2.54,良性结节为2.12±1.39。
  • 转移灶有效原子序数(Zeff)为10.0±0.94,良性结节为8.79±0.75。

诊断标准与关键数值

  • 诊断转移的IC截止值为3.10 mg/mL(p<0.001)。
  • 诊断转移的NIC截止值为0.29(p<0.001)。
  • 诊断转移的λHU截止值为3.57(p<0.001)。
  • 诊断转移的NICPA截止值为0.28(p<0.001)。
  • 诊断转移的Zeff截止值为9.34(p<0.001)。

临床应用与阅片要点

  • 日常阅片对甲状腺癌患者肺结节可加做双能CT碘图,测量IC和NIC辅助定性。
  • 对≥3 mm且<5 mm的小结节,双能CT参数仍有鉴别价值,避免漏诊小转移灶。
  • NIC和IC诊断准确性最高,可优先参考其截止值判断转移风险。

局限性

  • 回顾性单中心研究,样本量有限。
  • 转移判定部分依赖随访CT增大,可能存在时间偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To explore the importance of quantitative characteristics of dual-energy CT (DECT) between pulmonary metastasis and benign lung nodules in thyroid cancer.

METHODS: In this retrospective study, we identified 63 patients from our institution's database with pathologically proven thyroid cancer who underwent DECT to assess pulmonary metastasis. Among these patients, 22 had 55 pulmonary metastases, and 41 had 97 benign nodules. If nodules showed increased iodine uptake on I-131 single-photon emission computed tomography-computed tomography or increased size in follow-up CT, they were considered metastatic. We compared the clinical findings and DECT parameters of both groups and performed a receiver operating characteristic analysis to evaluate the optimal cutoff values of the DECT parameters.

RESULTS: Patients with metastases were significantly older than patients with benign nodules (p = 0.048). The DECT parameters of the metastatic nodules were significantly higher than those of the benign nodules (iodine concentration [IC], 5.61 ± 2.02 mg/mL vs. 1.61 ± 0.98 mg/mL; normalized IC [NIC], 0.60 ± 0.20 vs. 0.16 ± 0.11; NIC using pulmonary artery [NICPA], 0.60 ± 0.44 vs. 0.15 ± 0.11; slope of the spectral attenuation curves [λHU], 5.18 ± 2.54 vs. 2.12 ± 1.39; and Z-effective value [Zeff], 10.0 ± 0.94 vs. 8.79 ± 0.75; all p < 0.001). In the subgroup analysis according to nodule size, all DECT parameters of the metastatic nodules in all subgroups were significantly higher than those of the benign nodules (all p < 0.05). The cutoff values for IC, NIC, λHU, NICPA, and Zeff for diagnosing metastases were 3.10, 0.29, 3.57, 0.28, and 9.34, respectively (all p < 0.001).

CONCLUSIONS: DECT parameters can help to differentiate metastatic and benign lung nodules in thyroid cancer.

KEY POINTS: • DECT parameters can help to differentiate metastatic and benign lung nodules in patients with thyroid cancer. • DECT parameters showed a significant difference between benign lung nodules and lung metastases, even for nodules with diameters ≥ 3 mm and < 5 mm. • Among the DECT parameters, the highest diagnostic accuracy for differentiating pulmonary metastases from benign lung nodules was achieved with the NIC and IC, followed by the NICPA and λHU, and their cutoff values were 0.29, 3.10, 0.28, and 3.57, respectively.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Ha T, Kim W, Cha J, et al. Differentiating pulmonary metastasis from benign lung nodules in thyroid cancer patients using dual-energy CT parameters. Eur Radiol. 2021. PMID: 34564746. doi:10.1007/s00330-021-08278-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。